Zhejiang Medicine Co., Ltd. (SHA:600216)
China
· Delayed Price · Currency is CNY 16.83
-0.81 (-4.59%)
Mar 10, 2026, 11:30 AM CST
Zhejiang Medicine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 2,899 | 1,966 | 1,460 | 1,438 | 1,769 | 1,629 | Upgrade
|
| Short-Term Investments | - | - | - | - | 2.9 | 50 | Upgrade
|
| Trading Asset Securities | 288.33 | 294.91 | 328.31 | 447.29 | 454.4 | 270.73 | Upgrade
|
| Cash & Short-Term Investments | 3,188 | 2,261 | 1,788 | 1,885 | 2,226 | 1,950 | Upgrade
|
| Cash Growth | 62.31% | 26.41% | -5.15% | -15.30% | 14.17% | 10.91% | Upgrade
|
| Accounts Receivable | 1,729 | 1,830 | 1,419 | 1,501 | 1,594 | 1,402 | Upgrade
|
| Other Receivables | 70.61 | 194.79 | 239.14 | 67.35 | 105.17 | 141.38 | Upgrade
|
| Receivables | 1,800 | 2,025 | 1,658 | 1,568 | 1,699 | 1,544 | Upgrade
|
| Inventory | 1,981 | 2,133 | 2,011 | 1,995 | 1,873 | 1,480 | Upgrade
|
| Prepaid Expenses | - | - | - | 0.03 | 0.36 | 0.9 | Upgrade
|
| Other Current Assets | 152.8 | 166.46 | 143.88 | 207.17 | 236.04 | 143.85 | Upgrade
|
| Total Current Assets | 7,121 | 6,585 | 5,601 | 5,655 | 6,035 | 5,118 | Upgrade
|
| Property, Plant & Equipment | 5,976 | 6,121 | 6,019 | 5,618 | 5,360 | 4,513 | Upgrade
|
| Long-Term Investments | 146.99 | 156.51 | 166.21 | 144.51 | 126.07 | 195.48 | Upgrade
|
| Goodwill | - | - | 18.68 | 27.91 | 36.03 | - | Upgrade
|
| Other Intangible Assets | 623.64 | 684.4 | 744.3 | 747.68 | 728.81 | 409.75 | Upgrade
|
| Long-Term Deferred Tax Assets | 137.58 | 124.94 | 82.12 | 77.41 | 78.8 | 86.49 | Upgrade
|
| Long-Term Deferred Charges | 9.51 | 12.81 | 6.22 | 8.85 | 0.41 | 27.18 | Upgrade
|
| Other Long-Term Assets | 120.79 | 110.66 | 141.15 | 153.27 | 167.76 | 150.18 | Upgrade
|
| Total Assets | 14,136 | 13,795 | 12,780 | 12,433 | 12,532 | 10,500 | Upgrade
|
| Accounts Payable | 1,052 | 744.68 | 744.03 | 702.48 | 897.83 | 504.75 | Upgrade
|
| Accrued Expenses | 152.47 | 544.93 | 534.16 | 263.98 | 287.32 | 534.42 | Upgrade
|
| Short-Term Debt | 321.65 | 278.28 | 208.22 | 82.25 | 225.33 | 250.31 | Upgrade
|
| Current Portion of Long-Term Debt | 471.34 | 306.3 | 370.37 | 550.64 | - | 200.17 | Upgrade
|
| Current Portion of Leases | - | 0.56 | 0.3 | 0.28 | - | - | Upgrade
|
| Current Income Taxes Payable | 164.63 | 170.55 | 11.88 | 21.75 | 153.51 | 95.69 | Upgrade
|
| Current Unearned Revenue | 23.45 | 29.31 | 43.95 | 61.88 | 53.81 | 54.6 | Upgrade
|
| Other Current Liabilities | 367.94 | 494.84 | 565.52 | 782.11 | 1,407 | 284.22 | Upgrade
|
| Total Current Liabilities | 2,554 | 2,569 | 2,478 | 2,465 | 3,025 | 1,924 | Upgrade
|
| Long-Term Debt | 160.09 | 171.15 | 230.22 | 200.19 | 250.34 | 500.65 | Upgrade
|
| Long-Term Leases | 0.12 | 0.14 | 0.32 | 0.62 | 1.16 | - | Upgrade
|
| Long-Term Unearned Revenue | 133.51 | 104.6 | 84.16 | 54.11 | 53.08 | 34.24 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 2.47 | 21.12 | 11.38 | Upgrade
|
| Other Long-Term Liabilities | 76.78 | 82.2 | - | - | - | - | Upgrade
|
| Total Liabilities | 2,924 | 2,928 | 2,793 | 2,723 | 3,350 | 2,470 | Upgrade
|
| Common Stock | 961.64 | 961.64 | 964.98 | 965.13 | 965.13 | 965.13 | Upgrade
|
| Additional Paid-In Capital | 1,992 | 1,988 | 2,005 | 1,941 | 1,692 | 1,398 | Upgrade
|
| Retained Earnings | 8,281 | 7,700 | 6,682 | 6,417 | 6,195 | 5,371 | Upgrade
|
| Treasury Stock | -200 | - | -27.63 | -57.69 | -59.98 | -59.98 | Upgrade
|
| Comprehensive Income & Other | 20.4 | -1.36 | 5.77 | -5.27 | -13.99 | 0.41 | Upgrade
|
| Total Common Equity | 11,055 | 10,648 | 9,631 | 9,260 | 8,779 | 7,675 | Upgrade
|
| Minority Interest | 156.23 | 219.8 | 355.68 | 449.98 | 402.93 | 355.48 | Upgrade
|
| Shareholders' Equity | 11,211 | 10,868 | 9,986 | 9,710 | 9,182 | 8,030 | Upgrade
|
| Total Liabilities & Equity | 14,136 | 13,795 | 12,780 | 12,433 | 12,532 | 10,500 | Upgrade
|
| Total Debt | 953.19 | 756.43 | 809.44 | 833.97 | 476.82 | 951.12 | Upgrade
|
| Net Cash (Debt) | 2,234 | 1,504 | 978.89 | 1,051 | 1,749 | 998.53 | Upgrade
|
| Net Cash Growth | 84.02% | 53.67% | -6.90% | -39.89% | 75.16% | -9.87% | Upgrade
|
| Net Cash Per Share | 2.33 | 1.56 | 1.03 | 1.09 | 1.82 | 1.04 | Upgrade
|
| Filing Date Shares Outstanding | 947.91 | 961.64 | 902.84 | 958.3 | 958.3 | 958.3 | Upgrade
|
| Total Common Shares Outstanding | 947.91 | 961.64 | 902.84 | 958.3 | 958.3 | 958.3 | Upgrade
|
| Working Capital | 4,567 | 4,015 | 3,123 | 3,190 | 3,010 | 3,194 | Upgrade
|
| Book Value Per Share | 11.66 | 11.07 | 10.67 | 9.66 | 9.16 | 8.01 | Upgrade
|
| Tangible Book Value | 10,431 | 9,964 | 8,868 | 8,484 | 8,014 | 7,265 | Upgrade
|
| Tangible Book Value Per Share | 11.00 | 10.36 | 9.82 | 8.85 | 8.36 | 7.58 | Upgrade
|
| Buildings | - | 3,032 | 2,919 | 2,812 | 2,509 | 2,171 | Upgrade
|
| Machinery | - | 7,418 | 6,897 | 6,158 | 5,366 | 4,839 | Upgrade
|
| Construction In Progress | - | 982.5 | 931.69 | 825.71 | 1,119 | 638.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.